Source:http://linkedlifedata.com/resource/pubmed/id/12505532
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-12-30
|
pubmed:abstractText |
The dermorphin-derived tetrapeptide Tyr-D-Arg(2)-Phe-Sar(4) (TAPS) was tested for its ability to induce tolerance, cross-tolerance, withdrawal and its substitution properties in rats subjected to chronic intracerebroventricular (i.c.v.) infusions of mu-opiate receptor agonists. Tolerance and cross-tolerance were assessed by quantification of the thermally induced tail-flick response. Chronic intracerebroventricular infusion of TAPS resulted in antinociception at almost 1000-fold lower doses compared to morphine sulphate and [D-Ala(2), MePhe(4)Gly(ol)(5)]enkephalin (DAMGO). Tolerance to the antinociceptive effect of TAPS developed similar to DAMGO and morphine sulphate. Cross-tolerance to intracerebroventricular bolus injections of DAMGO, but not of TAPS, was evident in rats rendered tolerant to morphine sulphate and TAPS. Naloxone-induced withdrawal was equally pronounced in animals treated with morphine sulphate, DAMGO or TAPS. TAPS substituted for morphine sulphate and vice versa regarding the withdrawal syndrome in a cross-over experimental design. In contrast to DAMGO, TAPS retains its antinociceptive effect following bolus administration in rats rendered tolerant to mu-opioid receptor agonists.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Enkephalin, Ala(2)-MePhe(4)-Gly(5)-,
http://linkedlifedata.com/resource/pubmed/chemical/Morphine,
http://linkedlifedata.com/resource/pubmed/chemical/Naloxone,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/tyrosyl-arginyl-phenylalanyl-sarcosi...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
459
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12505532-Analgesics, Opioid,
pubmed-meshheading:12505532-Animals,
pubmed-meshheading:12505532-Dose-Response Relationship, Drug,
pubmed-meshheading:12505532-Drug Tolerance,
pubmed-meshheading:12505532-Enkephalin, Ala(2)-MePhe(4)-Gly(5)-,
pubmed-meshheading:12505532-Infusion Pumps,
pubmed-meshheading:12505532-Injections, Intraventricular,
pubmed-meshheading:12505532-Male,
pubmed-meshheading:12505532-Morphine,
pubmed-meshheading:12505532-Naloxone,
pubmed-meshheading:12505532-Oligopeptides,
pubmed-meshheading:12505532-Pain,
pubmed-meshheading:12505532-Rats,
pubmed-meshheading:12505532-Rats, Sprague-Dawley,
pubmed-meshheading:12505532-Substance Withdrawal Syndrome,
pubmed-meshheading:12505532-Substance-Related Disorders,
pubmed-meshheading:12505532-Time Factors
|
pubmed:year |
2003
|
pubmed:articleTitle |
Tolerance and dependence following chronic intracerebroventricular infusions of Tyr-D-Arg2-Phe-Sar4 (TAPS).
|
pubmed:affiliation |
Department of Cardiology and Pneumology, Georg-August-University, Robert-Koch-Str. 40, 37075, Göttingen, Germany. svonhof@gwdg.de
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|